Time of initial appearance of renal symptoms in the course of systemic lupus erythematosus as a prognostic factor for lupus nephritis

Modern Rheumatology

Volumn 19, Issue 3, 2009, Pages 293-301

  Takahashi, Yuko ^a   Mizoue, Tetsuya ^a   Suzuki, Akitake ^a   Yamashita, Hiroyuki ^a   Kunimatsu, Junwa ^a   Itoh, Kenji ^a   Mimori, Akio ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Lupus nephritis; Onset; Prognosis; SLE

Indexed keywords

CREATININE; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA ANTIBODY; METHYLPREDNISOLONE; PREDNISOLONE; PROTEIN; STEROID;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; DOSE RESPONSE; DRUG MEGADOSE; DRUG PULSE THERAPY; FEMALE; HISTOPATHOLOGY; HOSPITAL READMISSION; HUMAN; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN URINE LEVEL; PROTEINURIA; RELAPSE; REMISSION; RETREATMENT; RETROSPECTIVE STUDY; STEROID THERAPY; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT RESPONSE;

ADULT; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES;

EID: 67349269232     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-009-0154-4     Document Type: Article

References (12)

1. Chan TM, Li FK, Tang CSOT, Wong RWS, Fang GX, Ji YL, et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. N Engl J Med. 2000;343:1156-62.
2. Mok CC, Ying KY, Tang S, Leung Y, Lee KW, Ng WL, et al. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis. Arthritis Rheum. 2004;50:2559-68.
3. D'Agati VD, Appael GB. Lipus nephritis: Pathology and pathogenesis. In: Wallace DJ, Hahn BH, editors. Dubois' lupus erythematosus. 7th ed. Philadelphia: Lippincott Wiliams & Wikins; 2007. p. 1094-111.
4. Huong DLT, Papo T, Beaufils H, Wechsler B, Bletry O, Baumelou A, et al. Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center. Medicine. 1999;78:148-66.
5. Austin Ha III, Boumpas DT, Vaughan EM, Balow JE. Predicting renal outcomes in severe histologic nephritis: Contributions of clinical and histologic data. Kidney Int. 1994;45:544-50.
6. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004;15:241-50.
7. Yokoyama H, Wada T, Hara A, Yamahara J, Nakaya I, Kobayashi M, et al. The outcome and a new ISN/RPS 2003 classification of lupus nephritis in Japanese. Kidney Int. 2004;66:2382-8.
8. Schwartz MM, Lan SP, Bernstein J, Hill GS, Holley K, Lewis EJ. Role of pathology indices in the management of severe lupus glomerulonephritis. Lupus nephritis collaborative study group. Kidney Int. 1992;42:743-8.
9. Hill GS, Delahousse M, Nochy D, Balow JE. Predictive power of the second renal biopsy in lupus nephritis: Significance of macrophage. Kidney Int. 2001;59:304-16.
10. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271-7.
11. Cervera R, Khamashta MA, Font J, Sbastiani GD, Gil A, Lavilla P, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period. A comparison of early and late manifestations in a cohort of 1,000 patients. Medicine. 2003;82:299-307.
12. Illei GG, Takada K, Parkin D, Austin HA, Crane M, Yarboro CH, et al. Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy. Arthritis Rheum. 2002;46:995-1002.